These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 18512732

  • 21. Chemosensitization and delayed androgen-independent recurrence of prostate cancer with the use of antisense Bcl-2 oligodeoxynucleotides.
    Miayake H, Tolcher A, Gleave ME.
    J Natl Cancer Inst; 2000 Jan 05; 92(1):34-41. PubMed ID: 10620631
    [Abstract] [Full Text] [Related]

  • 22. Antisense protein kinase A RIalpha acts synergistically with hydroxycamptothecin to inhibit growth and induce apoptosis in human cancer cells: molecular basis for combinatorial therapy.
    Cho YS, Cho-Chung YS.
    Clin Cancer Res; 2003 Mar 05; 9(3):1171-8. PubMed ID: 12631623
    [Abstract] [Full Text] [Related]

  • 23. TP53INP1 as new therapeutic target in castration-resistant prostate cancer.
    Giusiano S, Baylot V, Andrieu C, Fazli L, Gleave M, Iovanna JL, Taranger-Charpin C, Garcia S, Rocchi P.
    Prostate; 2012 Sep 01; 72(12):1286-94. PubMed ID: 22213058
    [Abstract] [Full Text] [Related]

  • 24. Pomegranate extracts potently suppress proliferation, xenograft growth, and invasion of human prostate cancer cells.
    Albrecht M, Jiang W, Kumi-Diaka J, Lansky EP, Gommersall LM, Patel A, Mansel RE, Neeman I, Geldof AA, Campbell MJ.
    J Med Food; 2004 Sep 01; 7(3):274-83. PubMed ID: 15383219
    [Abstract] [Full Text] [Related]

  • 25. Epidermal growth factor receptor inhibitor (PD168393) potentiates cytotoxic effects of paclitaxel against androgen-independent prostate cancer cells.
    Pu YS, Hsieh MW, Wang CW, Liu GY, Huang CY, Lin CC, Guan JY, Lin SR, Hour TC.
    Biochem Pharmacol; 2006 Mar 14; 71(6):751-60. PubMed ID: 16413505
    [Abstract] [Full Text] [Related]

  • 26. Adenosine induces cell-cycle arrest and apoptosis in androgen-dependent and -independent prostate cancer cell lines, LNcap-FGC-10, DU-145, and PC3.
    Aghaei M, Karami-Tehrani F, Panjehpour M, Salami S, Fallahian F.
    Prostate; 2012 Mar 14; 72(4):361-75. PubMed ID: 21656837
    [Abstract] [Full Text] [Related]

  • 27. Down-modulation of survivin expression and inhibition of tumor growth in vivo by EZN-3042, a locked nucleic acid antisense oligonucleotide.
    Sapra P, Wang M, Bandaru R, Zhao H, Greenberger LM, Horak ID.
    Nucleosides Nucleotides Nucleic Acids; 2010 Feb 14; 29(2):97-112. PubMed ID: 20391197
    [Abstract] [Full Text] [Related]

  • 28. R115777 (Zarnestra)/Zoledronic acid (Zometa) cooperation on inhibition of prostate cancer proliferation is paralleled by Erk/Akt inactivation and reduced Bcl-2 and bad phosphorylation.
    Caraglia M, Marra M, Leonetti C, Meo G, D'Alessandro AM, Baldi A, Santini D, Tonini G, Bertieri R, Zupi G, Budillon A, Abbruzzese A.
    J Cell Physiol; 2007 May 14; 211(2):533-43. PubMed ID: 17192846
    [Abstract] [Full Text] [Related]

  • 29. Combined targeting of epidermal growth factor receptor and MDM2 by gefitinib and antisense MDM2 cooperatively inhibit hormone-independent prostate cancer.
    Bianco R, Caputo R, Caputo R, Damiano V, De Placido S, Ficorella C, Agrawal S, Bianco AR, Ciardiello F, Tortora G.
    Clin Cancer Res; 2004 Jul 15; 10(14):4858-64. PubMed ID: 15269162
    [Abstract] [Full Text] [Related]

  • 30. Down-regulation of Polo-like kinase 1 elevates drug sensitivity of breast cancer cells in vitro and in vivo.
    Spänkuch B, Heim S, Kurunci-Csacsko E, Lindenau C, Yuan J, Kaufmann M, Strebhardt K.
    Cancer Res; 2006 Jun 01; 66(11):5836-46. PubMed ID: 16740723
    [Abstract] [Full Text] [Related]

  • 31. Tanshinone IIA inhibits human prostate cancer cells growth by induction of endoplasmic reticulum stress in vitro and in vivo.
    Chiu SC, Huang SY, Chen SP, Su CC, Chiu TL, Pang CY.
    Prostate Cancer Prostatic Dis; 2013 Dec 01; 16(4):315-22. PubMed ID: 24042854
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Lenalidomide enhances the anti-prostate cancer activity of docetaxel in vitro and in vivo.
    Henry JY, Lu L, Adams M, Meyer B, Bartlett JB, Dalgleish AG, Galustian C.
    Prostate; 2012 Jun 01; 72(8):856-67. PubMed ID: 21968939
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Inhibitors of kinesin Eg5: antiproliferative activity of monastrol analogues against human glioblastoma cells.
    Müller C, Gross D, Sarli V, Gartner M, Giannis A, Bernhardt G, Buschauer A.
    Cancer Chemother Pharmacol; 2007 Feb 01; 59(2):157-64. PubMed ID: 16703323
    [Abstract] [Full Text] [Related]

  • 39. Apoptotic effect of tolfenamic acid in androgen receptor-independent prostate cancer cell and xenograft tumor through specificity protein 1.
    Choi ES, Shim JH, Jung JY, Kim HJ, Choi KH, Shin JA, Nam JS, Cho NP, Cho SD.
    Cancer Sci; 2011 Apr 01; 102(4):742-8. PubMed ID: 21241418
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.